OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
Richard M. Bergenstal, Ruth S. Weinstock, Chantal Mathieu, et al.
The Lancet (2024) Vol. 404, Iss. 10458, pp. 1132-1142
Closed Access | Times Cited: 11

Interpretable and multimodal fusion methodology to predict severe hypoglycemia in adults with type 1 diabetes
Francisco J. Lara-Abelenda, David Chushig-Muzo, Ana M. Wägner, et al.
Engineering Applications of Artificial Intelligence (2025) Vol. 144, pp. 110142-110142
Closed Access | Times Cited: 1

Nocturnal hypoglycemia in the era of continuous glucose monitoring
Bernhard Kulzer, Guido Freckmann, Ralph Ziegler, et al.
Journal of Diabetes Science and Technology (2024) Vol. 18, Iss. 5, pp. 1052-1060
Closed Access | Times Cited: 6

Pourquoi la variabilité glycémique est-elle si importante dans le risque d’hypoglycémie iatrogène : de la théorie à la pratique
L. Monnier, C Colette, Éric Renard, et al.
Médecine des Maladies Métaboliques (2025)
Closed Access

Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Obieda Altobaishat, Ahmed Farid Gadelmawla, Suliman Almohtasib, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 3
Open Access

Automated Insulin Delivery: A Milestone on the Road to Insulin Independence in Type 1 Diabetes
Catarina Limbert, Aaron J. Kowalski, Thomas Danne
Diabetes Care (2024) Vol. 47, Iss. 6, pp. 918-920
Open Access | Times Cited: 4

Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Viral N. Shah, Anne L. Peters, Guillermo E. Umpierrez, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 3

Moving from insulin substitution to the treatment of the underlying autoimmune disease in type 1 diabetes
Jantje Weiskorn, Thomas Danne
Hormone Research in Paediatrics (2024), pp. 1-8
Closed Access | Times Cited: 2

Closed-loop systems: a bridge to cell therapy for type 1 diabetes?
Sufyan Hussain, Katarina Braune, Shareen Forbes, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 11, pp. 782-784
Closed Access | Times Cited: 1

Cardiac autonomic neuropathy: impact on severe hypoglycemic unawareness and orthostatic hypotension in diabetic dysautonomia, a case series and review
Chao Wu, Rakesh Reddy Devireddy, Andrew Zazaian, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1

Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability
L. Monnier, C Colette, E. Renard, et al.
Diabetes & Metabolism (2024) Vol. 51, Iss. 1, pp. 101589-101589
Closed Access | Times Cited: 1

Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials
Junji Fujikura, Takayuki Anazawa, Tarō Toyoda, et al.
Journal of Diabetes Investigation (2024)
Closed Access | Times Cited: 1

Cost‐effectiveness of a Novel Hypoglycaemia Programme: The ‘HARPdoc vs BGAT’ RCT
Andrew Healey, Tayana Soukup, Nick Sevdalis, et al.
Diabetic Medicine (2024) Vol. 41, Iss. 6
Open Access

Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions
Yu Kuei Lin, Wen Ye, Helen Rogers, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 10, pp. 739-747
Closed Access

Psychometric validation of the hyperglycaemia avoidance scale UK (HAS‐UK)
Vicky McKechnie, Shaila Khan, Rob Saunders, et al.
Diabetic Medicine (2024) Vol. 41, Iss. 7
Open Access

Population-based study on the implementation of flash glucose monitoring and severe hypoglycemia in adults with type 1 diabetes
Pablo Rodríguez de Vera Gómez, Eduardo Mayoral Sánchez, Ángel Vilches‐Arenas, et al.
Diabetes Technology & Therapeutics (2024)
Closed Access

The impact of closed-loop automated insulin delivery systems on hypoglycaemia awareness in people living with type 1 diabetes: A systematic review and meta-analysis
Agathoklis Efthymiadis, Anastasios Bastounis, Linda Liu, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 2251-2261
Closed Access

Can Intranasal Naloxone Prevent Hypoglycemia-Associated Autonomic Failure?
Hamayle Saeed, Mary‐Elizabeth Patti
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access

Massive switch to an automated insulin delivery system in adults with type 1 diabetes previously treated with sensor-augmented pump due to high risk for hypoglycemia
Alex Mesa, Daría Roca, Montse Granados, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2024) Vol. 71, Iss. 9, pp. 390-396
Closed Access

Page 1 - Next Page

Scroll to top